IL-17A deletion ameliorated long-term cognitive impairment induced by multiple sevoflurane exposure in neonatal mice, inhibited the activation of the NF-κB signaling pathway, and led to alleviated neuroinflammation. The gene discussed is NFKB1; the disease is Cognitive impairment.